Product Images Gabapentin

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 9 images provide visual information about the product associated with Gabapentin NDC 16714-663 by Northstar Rx Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

equation of Cockcroft and Gault - gabapentin fig1

equation of Cockcroft and Gault - gabapentin fig1

This text appears to be a formula for calculating something with a person's age and weight, followed by a calculation involving creatinine levels, specifically mentioning values for female patients. The specific purpose or context is not provided, so it is not possible to determine what exactly is being calculated or why.*

fig-2 - gabapentin fig2

fig-2 - gabapentin fig2

The text appears to be a table with some headings and values related to pain scores and doses of medication (placebo and gabapentin). Without further context, it is difficult to provide a specific description or interpretation.*

fig-3 - gabapentin fig3

fig-3 - gabapentin fig3

This appears to be a table showing the mean pain scores for different treatments (placebo, Gatspntin 1600y, Gaagentn 2400sy) at different time periods (Baseline, Week 1, Week 2, Week 3, Week 4). Not much context is provided, so it's difficult to determine what type of pain or condition is being studied.*

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 3. Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies - gabapentin fig4

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

Figure 4. Responder Rate in Patients Receiving Gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - gabapentin fig5

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (100 Capsules Bottle) - gabapentin fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 100 mg (100 Capsules Bottle) - gabapentin fig6

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (100 Capsules Bottle) - gabapentin fig7

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 300 mg (100 Capsules Bottle) - gabapentin fig7

This is a medication guide for NDG 16714-662-01 Gabapentin Capsules of 300mg. It contains 100 capsules and the usual dosage is as mentioned in the package insert. The medication should be kept out reach of children and stored at appropriate temperatures. The manufacturer of this medication is Aurobindo Pharma Limited and it is distributed by Northstar Rx LLC. Contact details for medication guides are available at their website or by calling their helpline number.*

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 400 mg (100 Capsules Bottle) - gabapentin fig8

PACKAGE LABEL-PRINCIPAL DISPLAY PANEL - 400 mg (100 Capsules Bottle) - gabapentin fig8

This is a description of a medication called Gabapentin Capsules, USP, which come in a presentation of 100 capsules of 400mg, and it should be kept away from children at a temperature between 20°C to 25°C. It was manufactured by Aurobindo Pharma Limited and distributed by Northstar Rx LLC. It is highly recommended that patients read the Medication Guide provided separately by the pharmacist before use, and for more information to visit www.northstarind.com/products or call 1-800-206-7821.*

Chemical Structure - gabapentin str

Chemical Structure - gabapentin str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.